Linda A Moore1, Michael D Kaufman, Robert Algozzine
1UNC Charlotte, College of Health and Human Services,& Multiple Sclerosis Center, Carolinas HealthCare System, Charlotte, NC, USA. lmoore@uncc.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Patients experiencing skin reactions from injectable medications like interferon beta-1b for multiple sclerosis often stop treatment. This study developed a method to reduce these reactions, improving patient adherence to prescribed therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: